Germany – Pharmaceutical products – Arzneimittelrahmenrabattvertrag gemäß § 130a Abs. 8 bzw. § 130c Absatz 1 des Fünften
DAK-Gesundheit tender for Healthcare & Medical, worth €1, published in June 2025.
Sign-up only
See who won, the status and the award date.
A free account shows the winner. The status and the award date come with the US$19 3-day pass or a subscription.
Sign up free →Free account · cancel anytime
Contract description
Germany – Pharmaceutical products – Arzneimittelrahmenrabattvertrag gemäß § 130a Abs. 8 bzw. § 130c Absatz 1 des Fünften Sozialgesetzbuchs - Lytenava (Wirkstoff: Bevacizumab gamma), ATC S01LA08
Other tenders · DAK-Gesundheit
The buyer's full award list ranked by value, with the winning supplier, date and sector on every row — plus CSV / API export.
Winners and award dates are hidden on the public page. Sign up free to see them →
- ocds-ted-391843-2025€118 Jun 2025 Healthcare
- ocds-ted-467735-2025-8Not disclosed04 Mar 2025 Healthcare
- ocds-ted-467735-2025-7Not disclosed04 Mar 2025 Healthcare
Sign-up only
See who won, the status and the award date.
A free account shows the winner. The status and the award date come with the US$19 3-day pass or a subscription.
Sign up free →Free account · cancel anytime